Serum samples and 50% NAI values. Serum samples taken from CEIRS study. by Harrison Powell (9040128)

Scatter plot for the absolute decrease in CS rates (A) and the relative decrease in CS rates (B) from 2008 to 2016 among hospitals in Guangzhou grouped by their baseline CS rates. by Xiaoyan Xia (560153)

“…<p>A total of 112 hospitals with more than 100 live births both at baseline and in Stage 2 were included and were grouped by their baseline CS rates. One circle represents one hospital, with blue (<i>n</i> = 20), green (<i>n</i> = 36), orange (<i>n</i> = 34), and purple (<i>n</i> = 22) representing baseline CS rates of <30%, 30%–39%, 40%–49%, and ≥50%, respectively. …”

Decreasing fluconazole susceptibility of clinical South African <i>Cryptococcus neoformans</i> isolates over a decade by Serisha D. Naicker (8648370)

Effect of inhibitory antibodies and human serum on NA enzymatic function ELLA and NA Star. by Harrison Powell (9040128)

The first regression of log of confirmed cases vs consecutive days for 4 of the total of 50 countries is shown. by Adam Kaplin (10156481)

Conditioning with glucose and sodium ions decreases chemotaxis to sodium ions and glucose, respectively. by Masahiro Tomioka (430683)

Anaesthesia decreases stimulus-specific suppression on probe-responses only after communication context. by Luciana López-Jury (8601540)

TLR3 expression in BECs challenged with CsEVs (50 μg/mL) and rCsEVs (50 μg/mL). by Yuru Wang (846969)

Replication of recombinant H3N2 viruses in MDCK-SIAT1, MDCK or hNEC cultures with or without 245 NA glycosylation. by Harrison Powell (9040128)

Effect of neuraminidase inhibitory antibodies on virus growth. by Harrison Powell (9040128)

N1-specific anti-serum decreases replication of A(H1N1)pdm09 in HAE cells. by Anouk Smet (713884)

Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s. by Djaloul Karboua (16510091)

“…<p>Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.…”

Assessment of intratumoral CD3+ and CD8+ lymphocyte populations. by Gerik W. Tushoski-Alemán (17951809)

Subjects:

Expression of cytokines by CD3+ infiltration in PDAC. by Gerik W. Tushoski-Alemán (17951809)

Subjects:

Expression of cytokines by CD8+ infiltration in PDAC. by Gerik W. Tushoski-Alemán (17951809)

Subjects:

Clinicopathological characteristics of patient cohort. by Gerik W. Tushoski-Alemán (17951809)

Subjects:

Correlation of CD8+ infiltration and chemokines/cytokines. by Gerik W. Tushoski-Alemán (17951809)

Subjects:

Comparisons of infiltrating CD3+ and CD8+ lymphocytes and covariate analysis. by Gerik W. Tushoski-Alemán (17951809)

Subjects:

Correlation of CD3+ infiltration and chemokines/cytokines. by Gerik W. Tushoski-Alemán (17951809)

Subjects:

Dataset of patient cohort, CD3+ and CD8+ lymphocyte quantification, and inflammatory assay. by Gerik W. Tushoski-Alemán (17951809)

Subjects: